ERT acquires imaging solution from Cleveland Clinic

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, acquired ImageIQ, originally established as Cleveland Clinic’s Biomedical Imaging and Analysis Center. The acquisition enables ERT to offer advanced, end-to-end clinical trial imaging analysis using best-in-class technology that delivers compliant data for use in clinical development. “After conducting an exhaustive […]

The post ERT acquires imaging solution from Cleveland Clinic appeared first on CenterWatch News Online.

News

A modified poliovirus appears to trigger the body’s anti-tumor immunity. The new study showed promising results in human breast cancer cells and mice. Powered by WPeMatico

A new report from the WHO reveals that the current scope of new antibiotic development is far from what is needed to tackle drug resistance. Powered by WPeMatico

Certara, a provider of model-informed drug development and regulatory science, announced that Kyowa Hakko Kirin has joined the Simcyp Consortium and licensed the Simcyp Population-based Simulator. Kyowa Hakko Kirin is the 36th leading biopharmaceutical company and the 11th Japanese pharmaceutical company to join the Consortium. Member companies meet in a pre-competitive environment and work together to […]

A new early phase contract development and manufacturing organization (CDMO), Ardena, has launched following the merging of Pharmavize and Crystallics. The two companies came together in 2016 with backing from investor Mentha Capital. The new brand name, Ardena, reveals the increased service offering and complementary capabilities of Pharmavize in Belgium and Crystallics in the Netherlands. […]

Alexion Pharmaceuticals announced an operational plan to re-align the global organization with its refocused corporate strategy. The plan is expected to deliver approximately $270 million in GAAP and approximately $250 million in non-GAAP pre-tax savings annually by 2019. The restructuring will reduce the company’s global workforce by approximately 20%. The resulting savings will allow Alexion […]

ProQR Therapeutics has spun out Amylon Therapeutics, a privately-held company focused on the development of therapies for central nervous system (CNS) disorders, with seed funding from a group of institutional and private investors. As part of the transaction, ProQR has granted an exclusive license to Amylon to develop therapeutics for beta amyloid related disorders. Amylon […]

Clinical Trials and Medical Trials recruitment in the UK

Volunteer for Clinical Trials

ERT acquires imaging solution from Cleveland Clinic

News

Poliovirus kills off cancer cells, stops tumor regrowth

Drug resistance: WHO report ‘serious lack of new antibiotics’

Kyowa Hakko Kirin joins Certara’s Simcyp consortium

Pharmavize, Crystallics merge, launch Ardena

Alexion restructures, cuts workforce 20%

ProQR spins out Amylon Therapeutics for CNS therapeutics